NOT-DA-19-040: Notice of Correction to PAR-19-246 "Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25

Notice of Correction to PAR-19-246 "Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed)"

Notice Number: NOT-DA-19-040

Key Dates
Release Date: May 8, 2019

Related Announcements
PAR-19-246 -Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed)

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of the Notice is to correct the Key Dates in PAR-19-246 "Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Abuse and Addiction Scientists (R25 - Clinical Trials Not Allowed)"

Currently Reads:

Part 1. Overview Information

Key Dates

Application Due Date(s): June 12, 2019; September 13, 2020, September 15, 2021

AIDS Application Due Date(s): June 12, 2019; September 13, 2020, September 15, 2021

Advisory Council Review: August 2019, January 2020, January 2021

Expiration Date: September 16, 2021

Modified to Read:

Part 1. Overview Information

Key Dates

Application Due Date(s) : June 12, 2019; September 13, 2019, September 15, 2020

AIDS Application Due Date(s): June 12, 2019; September 13, 2019, September 15, 2020

Advisory Council Review: August 2019, January 2020, January 2021

Expiration Date:September 16, 2020

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Albert Avila, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-496-8804
Email:aavila@nida.nih.gov